Fleury acquires Unilab clinical lab for R$55M, expanding diagnostics footprint

Brazilian diagnostics company Fleury (FLRY3) announced the acquisition of Unilab Laboratório Clínico for R$55 million. Unilab's gross revenue over the last 12 months through May 2026 was R$65 million, indicating a strategic consolidation in Brazil's clinical laboratory market. The deal is a modest M&A move, likely to strengthen Fleury's regional presence and scale.